If you ask most people, they will say there are two types of people that put money in the stock market.
There are "investors" -- those who put money to work in fundamentally sound companies for the long term. Then there are "traders" -- those who buy stocks for a short-term gain, without much concern for the actual business.
But it's one thing to tell you this. I want to prove it to you with one of the most followed stocks of the past decade -- Apple (Nasdaq: AAPL).
You're no doubt familiar with Apple. You might have even owned some shares at some point. Maybe you still do.
Top High Dividend Companies To Own In Right Now: Belgacom SA (BELG)
Belgacom SA is a Belgium-based company registered under the Belgian public law that provides both fixed and mobile telecommunication services, including telephony, Internet and television services for both professional and private customers. Its activities are divided into five product lines: Packs (offering mixed all-in-one products, such as Internet together with Television and Mobile telephony); Proximus telephony, Internet, Television and Fixed telephony. It also offers its customers e-services (helping in account managing online), help and support through its Website. The Belgian State is the Company's major shareholder. Advisors' Opinion:- [By Namitha Jagadeesh]
Belgacom SA (BELG) rallied 9.1 percent to 18.34 euros, its biggest gain since at least 2004, after reporting second-quarter earnings before interest, taxes, depreciation, amortization and some items of 430 million euros. Analysts on average had estimated Ebitda of 414.2 million euros.
Top 5 Long Term Companies To Buy Right Now: Athlon Energy Inc (ATHL)
Athlon Energy Inc., incorporated on April 1, 2013, is an independent exploration and production company. The Company is a holding company and its sole assets are controlling equity interests in Athlon Holdings LP and its subsidiaries. The Company is focused on the acquisition, development and exploitation of unconventional oil and liquids-rich natural gas reserves in the Permian Basin. The Permian Basin spans portions of Texas and New Mexico and consists of three primary sub-basins: the Delaware Basin, the Central Basin Platform and the Midland Basin. The Company�� properties are located in the Midland Basin. Its drilling activity is focused on the vertical development of stacked pay zones, including the Spraberry, Wolfcamp, Cline, Strawn, Atoka and Mississippian formations, which it refers to collectively as the Wolfberry play. The Company's acreage position was 124,925 gross at May 31, 2013, which it grousp into three primary areas based on geographic location within the Midland Basin: Howard, Midland and Other and Glasscock. As of April 30, 2013, the Company operated up to eight vertical drilling rigs and has drilled 218 gross operated vertical Wolfberry wells. In February 2014, Athlon Energy Inc announced that subsidiary, Athlon Holdings LP completed the acquisition of certain oil and natural gas properties and related assets in the Midland Basin of West Texas.
As of March 15, 2013, there were 478 total rigs operating in the Permian Basin. The Company�� properties are located within the Midland Basin in areas with approximately 3,000 feet to 4,000 feet of stacked pay zones. Its vertical drilling program is targeting the Spraberry, Wolfcamp, Cline, Strawn, Atoka and Mississippian formations.
Howard
The Company operates four rigs in this area. As of May 31, 2013, the Company had 69,661 gross acres and an inventory of 1,577 gross (1,140 net) identified vertical drilling locations on 40-acre spacing and an additional 1,741 gross identified vertical drilling ! locations on 20-acre spacing. As of April 30, 2013, it had identified 506 gross horizontal drilling locations consisting of 147 gross Wolfcamp A locations, 172 gross Wolfcamp B locations, 25 gross Wolfcamp C locations, 111 gross Cline locations and 51 gross Mississippian locations.
Midland and Other
The Company operates two rigs in this area. As of May 31, 2013, the Company had 36,694 gross acres and an inventory of 424 gross (390 net) identified vertical drilling locations on 40-acre spacing and an additional 463 gross (414 net) identified vertical drilling locations on 20-acre spacing. As of April 30, 2013, it has identified 352 gross horizontal drilling locations consisting of 64 gross Wolfcamp A locations, 125 gross Wolfcamp B locations, 97 gross Wolfcamp C locations and 66 gross Cline locations.
Glasscock
The Company operates one rig in this area. As of May 31, 2013, it had 18,570 gross net acres and an inventory of 297 gross (267 net) identified vertical drilling locations on 40-acre spacing and an additional 400 gross identified vertical drilling locations on 20-acre spacing. As of April 30, 2013, it had identified 232 gross horizontal drilling locations consisting of 54 gross Wolfcamp A locations, 58 gross Wolfcamp B locations, 58 gross Wolfcamp C locations and 62 gross Cline locations.
Advisors' Opinion:- [By Matt Jarzemsky var popups = dojo.query(".socialByline .popC"); popups.forEach]
The drillers considered to be Parsley�� closest peers include Diamondback Energy Inc.(FANG), which has seen its shares rally 38% so far this year through Thursday. Athlon Energy Inc.(ATHL), another similar company, is up 43% this year and 116% since its August IPO.
Top 5 Long Term Companies To Buy Right Now: Arch Therapeutics Inc (ARTH)
Arch Therapeutics, Inc. (Arch), formerly Almah, Inc., incorporated on September 16, 2009, operates as a life science company developing polymers containing peptides intended to form gel-like barriers over wounds to stop or control bleeding. Arch is a medical device company offering an approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care. Arch�� products are in preclinical development. The first product, AC5, is designed for hemostasis in minimally invasive (laparoscopic) and open surgical procedures.
AC5
AC5 is a synthetic peptide consisting of naturally occurring amino acids. When squirted or sprayed onto a wound, AC5 intercalates into the nooks and crannies of the connective tissue where it builds itself into a physical, mechanical structure. That structure provides a barrier to leaking substances, including blood and other bodily fluids, regardless of type of surgery or, based on early data, clotting ability.
Advisors' Opinion:- [By John Udovich]
Laparoscopic surgery or minimally invasive surgery (MIS) is a type of surgical technique where�operations in the abdomen are performed through small incisions while small cap stocks ArthroCare Corporation (NASDAQ: ARTC), EDAP TMS S.A. (NASDAQ: EDAP), SafeStitch Medical Inc (OTCBB: SFES) and Arch Therapeutics Inc (OTCBB: ARTH) are all in some way focused on aiding minimally invasive procedures. According to a 2012 report produced by MedMarket Diligence, LLC, approximately 114 million surgical and procedure-based wounds occur annually worldwide,�including�36 million in the US, and perhaps�up to a quarter of these procedures can be described as laparoscopic in nature.�Moreover,�use of the technique is bound to increase�as�it reduces�pain and hemorrhaging plus leads to a�shorter recovery time.
- [By John Udovich]
Small cap stocks Derma Sciences Inc (NASDAQ: DSCI), Oculus Innovative Sciences, Inc (NASDAQ: OCLS)�and Arch Therapeutics Inc (OTCBB: ARTH) specialize or have a focus on wound care���a medical problem that has plagued mankind since the dawn of time. After all and think back to our Civil War when disease along with infections resulting from improper wound care probably killed more soldiers than actual battles. Even today, infection after surgery or after receiving a wound or injury of any kind is still a constant threat. And then there is the scaring that can result from any sort of invasive surgery or injury. With those thoughts in mind, here are three small cap wound care stocks trying address these problems:
- [By James E. Brumley]
With each passing day, the opportunity Arch Therapeutics Inc. (OTCBB:ARTH) is presenting to investors gets a little bit clearer... as clear as AC5. What's AC5? It's a hemostasis agent. In other words, it stops post-surgical bleeding. It doesn't do the job quite like anything else out there, though, and that's a good thing for current and/or future ARTH shareholders.
- [By Bryan Murphy]
When traders think of post-surgical wound management stocks, they may first think of names like Cytomedix, Inc. (OTCBB:CMXI) or Alliqua Inc. (OTCMKTS:ALQA). And well they should. Both companies have something of a history in the arena. ALQA is the purveyor of SilverSeal and Hydress antibiotic bandages, while CMXI is the developer of the AutoloGel system, which induces an affected patient's on body to do what it's supposed to do if there's a wound that won't heal. Cytomedix also makes the Angel platelet-rich plasma (PRP) delivery system. There's a relatively new name to add to the list of game-changing stocks in wound-management industry, however.... Arch Therapeutics Inc. (OTCBB:ARTH). The company is developing - well, has developed - a product called AC5 that nips post-surgical bleeding in the bud, largely negating the need for other post-surgical bleeding-control measures.
Top 5 Long Term Companies To Buy Right Now: Roche Holding AG (ROG.VX)
Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated companies around the world. It discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. The Company has two divisions: Pharmaceuticals and Diagnostics. Pharmaceuticals are divided into two sub-divisions: Roche Pharmaceuticals and Chugai. It operates in the United States, Western Europe, Japan, CEMAI (Central and Eastern Europe, Middle East, Africa, Central Asia, Indian Subcontinent), Latin America, Asia-Pacific and Other regions. Diagnostics include five business areas: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. It operates in five geographical regions: Europe, Middle East and Africa (EMEA); North America; Asia-Pacific; Latin America, and Japan. Advisors' Opinion:- [By Lauren Pollock]
Roche Holding AG(ROG.VX) has entered a pact with Prothena Corp.(PRTA) PLC to develop and commercialize a treatment the clinical-stage biotechnology firm is developing for Parkinson’s disease. In after-hours trading, Prothena’s stock rose 8.6% to $29.75 premarket.
No comments:
Post a Comment